| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.11B | 114.36B | 59.21B | 36.55B | 50.50B | 44.69B |
| Gross Profit | 27.20B | 48.00B | 21.50B | 13.89B | 16.15B | 12.07B |
| EBITDA | 7.65B | 15.14B | 8.00B | 5.96B | 2.77B | 2.57B |
| Net Income | 3.00B | 12.29B | 3.79B | 7.32B | -4.94B | -3.21B |
Balance Sheet | ||||||
| Total Assets | 130.23B | 170.85B | 121.39B | 79.33B | 72.09B | 111.28B |
| Cash, Cash Equivalents and Short-Term Investments | 20.30B | 45.57B | 14.53B | 32.07B | 32.66B | 13.93B |
| Total Debt | 63.31B | 78.93B | 50.83B | 32.99B | 32.34B | 55.77B |
| Total Liabilities | 87.02B | 113.54B | 75.93B | 39.44B | 39.22B | 71.53B |
| Stockholders Equity | 39.46B | 50.20B | 41.45B | 39.89B | 32.87B | 37.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.21B | -11.05B | 2.32B | 3.54B | -4.40B |
| Operating Cash Flow | 0.00 | 13.96B | 5.09B | 3.72B | 4.85B | -2.89B |
| Investing Cash Flow | 0.00 | 2.04B | -21.30B | -5.01B | 36.96B | 1.23B |
| Financing Cash Flow | 0.00 | 15.04B | -1.34B | 692.00M | -23.16B | 292.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥99.02B | 32.32 | 1.46% | 1.18% | 15.23% | 37.37% | |
66 Neutral | ¥104.64B | 19.98 | ― | 2.19% | 3.42% | 7.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥54.12B | 492.13 | ― | 0.11% | 16.94% | 3.63% | |
61 Neutral | ¥114.53B | 8.03 | 15.81% | 2.93% | 12.51% | 12.42% | |
58 Neutral | ¥68.13B | 6.42 | ― | ― | 93.14% | 252.55% | |
57 Neutral | ¥3.29B | 15.32 | ― | ― | 33.81% | -13.58% |